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W arm blood cardioplegic perfusion has been pro-posed as a better method of myocardial protection
than conventional hypothermic cardioplegic regimens
because of better oxygen delivery, better adenosine
triphosphate (ATP) generation, and avoidance of the
negative effects of hypothermia.1-4 Administration of
cardioplegic solutions through the coronary sinus has
gained importance in cardiac operations because of the
simplicity of the transatrial approach.5 Clinical and
Objective: The purpose of this study was to determine whether retrograde
continuous normothermic blood cardioplegic perfusion provides better
protection to ischemic areas of the left and right ventricles than does
antegrade continuous normothermic blood cardioplegic perfusion.
Localized phosphorus 31 magnetic resonance spectroscopy was used to
monitor the changes in energy metabolism and intracellular pH in the
ventricles of pig hearts. Methods: Ten isolated pig hearts received 20 min-
utes of antegrade continuous normothermic blood cardioplegic perfusion
for collection of control (baseline) data, followed by 60 minutes of either
antegrade continuous normothermic blood cardioplegic perfusion (n = 5)
or retrograde continuous normothermic blood cardioplegic perfusion (n
= 5) with occlusion of the left anterior descending and the right coronary
arteries. The hearts were then subjected to antegrade continuous nor-
mothermic blood cardioplegic perfusion for 20 minutes. The perfusion
pressures were maintained between 80 and 100 mm Hg and between 38
and 43 mm Hg during antegrade and retrograde continuous normother-
mic blood cardioplegic perfusions, respectively. Intracellular pH and cre-
atine phosphate, inorganic phosphate, and adenosine triphosphate levels
were measured continuously in each ventricle by means of localized
phosphorus 31 magnetic resonance spectroscopy with 2 surface coils.
Results: Both antegrade and retrograde continuous normothermic blood
cardioplegic perfusion resulted in a significant increase in inorganic
phosphate level and decreases in creatine phosphate level, adenosine
triphosphate level, and intracellular pH. No significant differences in
these changes were observed between the two groups. The creatine phos-
phate and adenosine triphosphate levels were significantly lower in the
right ventricle than in the left ventricle during retrograde continuous
normothermic blood cardioplegic perfusion. On reperfusion, the inor-
ganic phosphate level, creatine phosphate level, and intracellular pH
recovered completely; however, no recovery in the adenosine triphos-
phate level was seen in the ventricles of either group. Conclusions:
Retrograde continuous normothermic blood cardioplegic perfusion does
not provide better protection to ischemic areas of the ventricles than does
antegrade continuous normothermic blood cardioplegic perfusion under
our experimental conditions. (J Thorac Cardiovasc Surg 1999;117:994-
1003)
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experimental reports have demonstrated good results
with retrograde continuous normothermic blood car-
dioplegic perfusion in patients undergoing heart
surgery.1,6,7 Research into retrograde continuous nor-
mothermic blood cardioplegic perfusion is still limited,
however, and results are controversial.8,9 Nonuniform
delivery of cardioplegic solution to the right ventricle
has been noted during retrograde perfusion.10,11 Our
previous study with isolated normal pig hearts showed
that retrograde continuous normothermic blood cardio-
plegic perfusion does not preserve normal energy
metabolism and provides less protection to the right
ventricle than to the left ventricle.12
Although it has been demonstrated both in animals
and in human beings that retrograde cold cardioplegic
perfusion provides better protection to an acute
ischemic area than does antegrade cold cardioplegic
perfusion, it has not been determined whether retro-
grade continuous normothermic blood cardioplegic per-
fusion provides better protection to ischemic areas of
the left and right ventricles than does antegrade contin-
uous normothermic blood cardioplegic perfusion. In
this study localized phosphorus 31 magnetic resonance
(MR) spectroscopy with 2 surface coils12 was used dur-
ing antegrade and retrograde continuous normothermic
blood cardioplegic perfusion to monitor the changes in
energy metabolism and intracellular pH in ischemic
areas of the right and the left ventricles.
Material and methods
Surgical preparation. Ten pigs (commercial farm
Yorkshire cross-bred) of either sex weighing 28 to 35 kg were
used in this study and received humane care according to the
“Guide to the Care and Use of Experimental Animals” pub-
lished by the Canadian Council on Animal Care.13 All ani-
mals were medicated before the study intramuscularly with
ketamine hydrochloride (20 mg/kg), xylazine (2.2 mg/kg),
and atropine sulfate (0.03 mg/kg). Anesthesia was initiated
with 4% isoflurane and maintained with 1.5 to 2% isoflurane
through an anesthesia system (Ohmeda Excel 210; Datex-
Ohmeda Division, Instrumentarium Corp, Helsinki, Finland).
Approximately 300 mL blood was withdrawn from the pig
after all cannulation was finished, and this was used as a min-
imal prime for the perfusion system.
As described previously,12,14 a median sternotomy was per-
formed and the heart was exposed after the pericardium was
opened. Intravenous heparin was administered at 500 U/kg.
The ascending aorta was cannulated with an RMI 9F, triple-
lumen antegrade cardioplegic cannula (Canadian Cardio-
vascular, Mississauga, Ontario, Canada). The 3 lumina simul-
taneously provided a pressure line, a perfusion line, and a
vent or venous sampling port during retrograde continuous
normothermic blood cardioplegic perfusion. After occlusion
of the branches of the aortic arch and the aortic arch, perfu-
sion down the aortic root was initiated with oxygenated blood
by means of a membrane oxygenator (CAPIOX 308; Terumo
Corporation, Tokyo, Japan) with a roller pump (COBE model
C22.2; COBE BCT, Inc, Lakewood, Colo). At the same time
the superior and inferior venae cavae were clamped and the
pulmonary artery and both atria were opened to prevent dis-
tention of the heart. The perfusion pressure in the aorta was
monitored continuously and maintained at 80 to 100 mm Hg
with a concurrent flow rate of 100 to 200 mL/min. The heart
and lungs were isolated en bloc, with care taken not to cut the
esophagus to avoid contamination of the collected blood. The
weight of the heart was distributed equally through suspen-
sion from the aorta to avoid aortic valve incompetence caused
by aortic distortion. The hemiazygos vein was closed with a
purse-string suture and the coronary sinus was cannulated
with a Sarns 13F dual-lumen retrograde cardioplegic perfu-
sion cannula with manual inflatable balloon (3M Health
Care, Ann Arbor, Mich), thus providing retroperfusion and
pressure monitoring. The cannula was advanced to just before
the posterior vein of the left ventricle. Segments about 0.5 cm
long of both the left anterior descending coronary artery and
the right coronary artery were isolated and a hydrovascular
occluder (In Vivo Metric, Healdsburg, Calif) was placed
around each artery. Heart arrest was achieved by adding
potassium chloride to the reservoir to reach a final concentra-
tion of 18 ± 2 mmol/L. The hematocrit value was maintained
at 17% to 22% (the reference value for pigs is approximately
30%). The PCO2 and PO2 were maintained between 35 and 45
mm Hg and between 300 and 440 mm Hg, respectively, by
adjusting the total gas flow and the percentage of carbon
dioxide gas. Blood pH was maintained between 7.35 and
7.45. All the electrolyte levels except that of potassium were
kept within physiologic ranges. The temperature was main-
tained at 37°C with a circulated warm water bath system
(Lauda Dr R. Wobser Gmbh & Co KG, Postfach, Germany).
The perfusion system was designed to allow remote
switching to either antegrade or retrograde continuous nor-
mothermic blood cardioplegic perfusion from outside the MR
instrument to avoid any repositioning of the heart probe.
During antegrade continuous normothermic blood cardio-
plegic perfusion the perfusion pressure measured at the
ascending aorta was maintained at 80 to 100 mm Hg with a
concurrent pump flow of 100 to 200 mL/min before and after
occlusion of the coronary arteries and of 80 to 100 mL/min
during occlusion of the coronary arteries. A retrograde perfu-
sion pressure of 38 to 43 mm Hg at the coronary sinus was
achieved by adjusting the pump flow (120-200 mL/min).
Protocol. The protocol for this study was 20 minutes of
antegrade continuous normothermic blood cardioplegic per-
fusion (baseline), then 60 minutes of either antegrade or ret-
rograde continuous normothermic blood cardioplegic perfu-
sion with occlusion of the left anterior descending and right
coronary arteries, and then finally 20 minutes of reperfusion
with antegrade continuous normothermic blood cardioplegic
perfusion. Ten pigs were randomly divided into 2 groups, the
antegrade group (n = 5) and the retrograde group (n = 5).
996 Ye et al The Journal of Thoracic and
Cardiovascular Surgery
May 1999
MR spectroscopy. As described previously,12 all experi-
ments were performed with a Bruker MSLX spectrometer
(Bruker Instruments Inc, Billerica, Mass) equipped with a 7-
T, 40-cm horizontal-bore magnet. Two similar surface coils
15 mm in diameter were used; one was placed against the left
ventricular wall (over the area supplied by the left anterior
descending coronary artery) and the other was placed against
the right ventricular wall (over the area supplied by the right
coronary artery). The separation of the 2 coils was about 10
cm. The acquisition of data from the 2 coils was time-inter-
leaved; only 1 coil was connected to the spectrometer at a
time. Spectra were obtained alternately every 2 minutes from
the left and right ventricles by means of a single pulse-and-
acquire sequence. The pulse length was 60 m s, and 1024
complex data points were acquired in 102 ms after the exci-
tation pulse. The repetition time was 2 seconds, and 60 acqui-
sitions were averaged in 2 minutes. This repetition time was
used for signal-to-noise considerations. Although the
metabolites are not fully relaxed with a repetition time of 2
seconds, the percentage change in each metabolite is not
affected by partial saturation in the absence of any change in
relaxation times of the metabolites. Field homogeneity was
optimized by global shimming on the proton signal.12
Release of creatine kinase. Afferent and efferent blood
samples were obtained before, during, and after occlusion of
the left anterior descending and right coronary arteries for
creatine kinase (CK) measurements. Activity of CK was
determined by an enzymatic reaction method (Sigma CK-10,
Sigma Chemical Co, St Louis, Mo) monitored at 340 nm (DU
650 spectrophotometer, Beckman Coulter, Inc, Fullerton,
Calif), according to the procedures described in the manufac-
turer’s manual. CK release was calculated according to the
following formula: CK release (in units per minute per 100
grams of tissue) = (CK level in efferent blood [in units per
liter] – CK level in afferent blood [in units per liter]) ·
Antegrade or retrograde perfusion flow (in liters per minute)
÷ Heart weight (in grams).
Needle biopsies for high-performance liquid chromato-
graphic analyses. Transmural biopsy specimens were ob-
tained with a biopsy needle from the nonischemic and
ischemic areas of the left and right ventricles just before com-
pletion of the experiments and were immediately immersed
in liquid nitrogen. The tissue samples were then freeze-dried
(The VirTis Company, Gardiner, NY) to determine myocar-
dial concentrations of ATP, adenosine diphosphate, adenosine
monophosphate, creatine phosphate, and creatine. The com-
pounds were measured by high-performance liquid chro-
matography (HPLC; Waters 510 pump, Waters 996
Photodiode Array Detector; Waters Corporation, Chroma-
tography Division, Milford, Mass) with the gradient paired-
ion chromatographic technique described previously.15
Tissue water content. Tissue samples of approximately 2
g obtained at the end of the experiments from the nonis-
chemic and ischemic areas of the left and right ventricles
were incubated at 60°C until constant weight was reached
(approximately 4 days). Wet and dried tissue weights were
obtained before and after incubation, respectively. Tissue
water content (as a percentage) was calculated according to
the following formula: Tissue water content (%) = (Wet tis-
sue weight – Dried tissue weight)/Wet tissue weight · 100%.
Data analysis. The heights of the MR spectral peaks were
used to determine the relative changes in inorganic phosphate,
creatine phosphate, and ATP, because the width of the MR sig-
nals did not change during the course of the experiments. The
heights of MR spectral peaks were obtained by means of in-
house analysis software (Allfit).16 The intracellular pH was
calculated from the chemical shift of the inorganic phosphate
peak.17 Three peaks arising from ATP were observed in the
MR spectra (g , a , and b ). The b -ATP peak was used to follow
the changes in ATP. The values of the b -peak of ATP and the
peaks of creatine phosphate, inorganic phosphate and intra-
cellular pH during the initial control antegrade continuous
normothermic blood cardioplegic perfusion period were aver-
aged across 4 spectra and used as baseline levels. During
occlusion of the coronary arteries and reperfusion the values
of the b -peak of ATP and the peaks of creatine phosphate,
inorganic phosphate, and intracellular pH were averages of 2
spectra and expressed as a percentage of the baseline level
(100%) obtained during initial antegrade cardioplegic perfu-
sion before occlusion of the coronary arteries.
The data are presented as the mean ± SEM. A repeated-
measures analysis of variance and the Duncan test were used
for comparison of HPLC data from different regions within
the group and for comparison of MR spectroscopic data at
different time points within the group. Simultaneous 95%
confidence intervals were calculated with the Bonferroni
method.18 Student t tests were performed to compare the data
(MR spectroscopy, HPLC, tissue water content, and CK
release) between the antegrade and retrograde groups or
between the left and right ventricles. In addition, standard
95% confidence intervals were calculated for comparison
between the antegrade and retrograde groups. The statistical
software used for data analysis was STATISTICA 5.1 for
Windows (StatSoft Inc, Tulsa, Okla).
Results
Antegrade versus retrograde continuous nor-
mothermic blood cardioplegic perfusion. During ini-
tial antegrade continuous normothermic blood cardio-
plegic perfusion (before occlusion of the coronary
arteries), MR spectroscopy showed stable levels of cre-
atine phosphate and ATP, with little evidence of inor-
ganic phosphate and with intracellular pH within the
reference range in both ventricles (left ventricle 7.40 ±
0.05 and right ventricle 7.36 ± 0.05) in both groups.
After occlusion of the coronary arteries neither ante-
grade nor retrograde continuous normothermic blood
cardioplegic perfusion maintained normal aerobic
energy metabolism in the ischemic areas of the ventri-
cles, as indicated by a significant increase in the inor-
ganic phosphate level (Fig 1) and decreases in the cre-
atine phosphate level (Fig 2), ATP level (Fig 3), and
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intracellular pH (Fig 4). Among these changes, the
increase in the inorganic phosphate level and the
decrease in the level of creatine phosphate reached
maxima at 20 to 30 minutes of occlusion with both
antegrade and retrograde continuous normothermic
blood cardioplegic perfusion. No significant difference
Fig 1. Inorganic phosphate (Pi) level in ischemic area of left ventricle (LV) and right ventricle (RV) during ante-
grade and retrograde cardioplegic perfusion. Level of inorganic phosphate during initial antegrade cardioplegic
perfusion (A-b) was used as baseline (100%). O, Occlusion of coronary arteries; A-r, antegrade cardioplegic per-
fusion reperfusion. Error bars represent SEM.
Fig 2. Creatine phosphate (PCr) level in ischemic area of left ventricle (LV) and right ventricle (RV) during ante-
grade and retrograde cardioplegic perfusion. Level of creatine phosphate during initial antegrade cardioplegic
perfusion (A-b) was used as baseline (100%). O, Occlusion of coronary arteries; A-r, antegrade cardioplegic per-
fusion reperfusion. Error bars represent SEM.
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was observed between the antegrade and retrograde
groups (Figs 1 and 2). A continuous decrease in the
ATP level was observed in the ischemic areas in both
groups during the 60-minute occlusion of the coronary
arteries. No significant difference was seen between
the 2 groups (Fig 3). Both antegrade and retrograde
Fig 3. ATP level in ischemic area of left ventricle (LV) and right ventricle (RV) during antegrade and retrograde car-
dioplegic perfusion. Level of ATP during initial antegrade cardioplegic perfusion (A-b) was used as baseline (100%).
O, Occlusion of coronary arteries; A-r, antegrade cardioplegic perfusion reperfusion. Error bars represent SEM.
Fig 4. Intracellular pH in ischemic area of left ventricle (LV) and right ventricle (RV) during antegrade and ret-
rograde cardioplegic perfusion. A-b, antegrade cardioplegic perfusion baseline; O, occlusion of coronary arteries;
A-r, antegrade cardioplegic perfusion reperfusion. Error bars represent SEM.
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continuous normothermic blood cardioplegic perfusion
resulted in a continuous decrease in intracellular pH in
the ischemic areas of both ventricles during the 60-
minute occlusion of the coronary arteries (Fig 4). On
release of the occlusion and reperfusion with antegrade
continuous normothermic blood cardioplegic solution,
immediate and complete recoveries of the inorganic
phosphate level, creatine phosphate level, and intracel-
lular pH were observed in both groups; however, the
concentrations of ATP did not return to preocclusion
values (Figs 1-4).
The levels of metabolites determined by HPLC at the
end of the experiments are shown in Table I. The con-
centration of ATP in the nonischemic myocardium
obtained from the antegrade group was similar to our
previous finding in normal pig hearts and was used as
the reference control value. In both groups the concen-
tration of ATP was significantly lower than the reference
control value in the ischemic, reperfused myocardium,
indicating incomplete recovery of ATP after reperfu-
sion, which is consistent with the MR spectroscopic
findings. No significant difference in ATP concentration
was observed between the antegrade and retrograde
groups. The level of ATP determined by HPLC was
similar to that obtained from MR spectroscopy during
reperfusion (Table II). The concentrations of creatine
phosphate, creatine, adenosine diphosphate, total crea-
tine (creatine phosphate plus creatine), and adenosine in
the ischemic areas were similar to those in the nonis-
chemic areas in the antegrade and retrograde groups.
The concentration of adenosine monophosphate was
low (<0.001 m mol/g dry weight) in most specimens.
The release of CK appeared to be higher in the retro-
grade group than in the antegrade group at 10 minutes
of occlusion and 20 minutes of reperfusion; however,
no significant difference in CK release was found
Table I. Metabolite levels in the left and right ventricles at the end of the experiments
ATP Creatine phosphate Creatine phosphate + creatine
Area Antegrade Retrograde* Antegrade Retrograde* Antegrade Retrograde*
Left ventricular nonischemic area 29 ± 1.0 28 ± 1.1 66 ± 7.3 78 ± 3.1 97 ± 4.4 104 ± 4.5
Left ventricular ischemic area 24 ± 2.7 23 ± 2.3 78 ± 5.0 76 ± 8.1 100 ± 6.5 102 ± 8.5
Statistical significance P = .025† P = .021†
Right ventricular nonischemic area 26 ± 1.5 21 ± 2.5 57 ± 3.3 60 ± 8.1 79 ± 3.2 80 ± 7.1‡
Statistical significance P = .017‡ P = .004‡ P = .014‡
Right ventricular ischemic area 21 ± 3.0 18 ± 1.8 64 ± 13.2 76 ± 3.5 85 ± 12.1‡ 93 ± 2.2
Statistical significance P = .012† P = .005‡ P = .002‡
Data were obtained by HPLC. The concentrations are shown as micromoles per gram dry weight and mean ± SEM.
*Retrograde continuous normothermic blood cardioplegic perfusion versus antegrade continuous normothermic blood cardioplegic perfusion (no significant difference
in any area).
†P < .05 (right ventricular ischemic area versus right ventricular nonischemic area or left ventricular ischemic area versus left ventricular nonischemic area within
the same group).
‡P < .05 (right ventricular nonischemic area versus left ventricular nonischemic area or right ventricular ischemic area versus left ventricular ischemic area within
the same group).
Table II. ATP levels in the ischemic areas during reperfusion
Left ventricular ischemic area Right ventricular ischemic area
Assay method Antegrade Retrograde Antegrade Retrograde
MR spectroscopy (n = 5) 81 ± 4.9 77 ± 5.3 77 ± 8.0 66 ± 5.3
HPLC (n = 5)* 82 ± 2.9 79 ± 2.5 80 ± 2.5 70 ± 2.3
Statistical significance† P = .50 P = .75 P = .74 P = .51
Values are expressed as percentages relative to reference control levels. The reference control levels for MR spectroscopy were the baseline percentage levels (100%)
obtained during the antegrade cardioplegic perfusion period before occlusion of the coronary arteries. For HPLC the level measured in the nonischemic area of the
left ventricle from the antegrade group was used as the reference control value for the ischemic areas of the left ventricle in both antegrade and retrograde groups.
The level measured in the nonischemic area of the right ventricle in the antegrade continuous normothermic blood cardioplegic perfusion group was used as the
reference control level for the ischemic areas of the right ventricle in both the antegrade and retrograde groups.
*The percentage changes were calculated from the means of 5 experiments in each subgroup (e.g. ischemic area of left ventricle in the antegrade group, ischemic
area of left ventricle in the retrograde group, ischemic area of right ventricle in the antegrade group, and ischemic area of right ventricle in the retrograde group) and
the SE of the quotient estimated as root mean square error.
†Student t test.
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between the 2 groups (Fig 5). The tissue water content
in the ischemic, reperfused myocardium (left ventricle
in antegrade group 85.6% ± 0.5%, left ventricle in ret-
rograde group 86.0% ± 0.9%; right ventricle in ante-
grade group 86.2% ± 0.7%, right ventricle in retrograde
group 86.4% ± 0.2%) was similar to that in normal
myocardium (left ventricle in antegrade group 86.2% ±
0.5%, left ventricle in retrograde group 86.8% ± 0.3%;
right ventricle in antegrade group 87.1% ± 0.5%, right
ventricle in retrograde group 87.5% ± 0.3%), and no
difference was observed between the antegrade and ret-
rograde groups.
Right ventricle versus left ventricle. The patterns of
changes in the ATP, creatine phosphate, and inorganic
phosphate levels and in intracellular pH during the
experiments were similar in the left and right ventricles
of both groups (Figs 1-4). However, in both groups
more inorganic phosphate accumulated in the left ven-
tricle than in the right ventricle during occlusion of the
coronary arteries (Fig 1). The reductions in creatine
phosphate and ATP concentrations seemed to be more
severe and rapid during occlusion of the coronary arter-
ies in the retrograde group in the right ventricle than in
the left ventricle (Figs 2 and 3). The intracellular pH
showed similar decreases during occlusion of the coro-
nary arteries in both ventricles in both groups (Fig 4).
Inorganic phosphate level, creatine phosphate level,
and intracellular pH, but not ATP level, returned to
baseline after release of the occlusion and reperfusion
in both ventricles of both groups.
No difference in tissue water content was observed
between the 2 ventricles in either group. According to
HPLC measurements, during retrograde continuous
normothermic blood cardioplegic perfusion the con-
centrations of ATP in the normal and ischemic
myocardium appeared to be lower in the right ventricle
than in the left ventricle (Table I). This indicates that
some injury occurred not only in the ischemic zone but
also in the nonischemic zone of the right ventricle dur-
ing retrograde continuous normothermic blood cardio-
plegic perfusion, which is consistent with our previous
finding in normal pig hearts.12 Significantly lower con-
centrations of total creatine (creatine phosphate plus
creatine) were observed in both the ischemic and non-
ischemic areas of the right ventricle than in the respec-
tive areas of the left ventricle in both the retrograde and
antegrade groups (Table I).
Discussion
Under our experimental conditions the significant
findings were as follows: (1) Neither antegrade nor ret-
rograde continuous normothermic blood cardioplegic
perfusion completely prevented ischemic energy metab-
olism in the ischemic area. Retrograde continuous nor-
mothermic blood cardioplegic perfusion did not provide
better protection to the ischemic area than did antegrade
continuous normothermic blood cardioplegic perfusion.
These findings are different from those obtained with
cold cardioplegic perfusion. (2) The ischemic area of
the right ventricle appeared to be less protected than that
Fig 5. CK release from hearts during antegrade and retrograde cardioplegic perfusion. A-b, antegrade cardioplegic
perfusion baseline; A-r, antegrade cardioplegic perfusion reperfusion. Error bars represent SEM.
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of the left ventricle during retrograde continuous nor-
mothermic blood cardioplegic perfusion. (3) Damage to
the ischemic area did not appear to be severe during 60
minutes of either antegrade or retrograde continuous
normothermic blood cardioplegic perfusion, as indicat-
ed by complete recovery of creatine phosphate and inor-
ganic phosphate levels and of intracellular pH, by the
lack of a significant release of CK, and by the lack of an
increase in tissue water in the ischemic area after reper-
fusion. The small reduction in ATP concentration
observed in this study does not appear to be sufficiently
severe to cause irreversible damage to myocardium. It
has been reported that a decrease in ATP content to less
than 35% to 40% of preischemic levels is associated
with irreversible damage.19,20
The efferent blood samples used to determine the
release of CK were obtained from the ascending aorta
during retrograde continuous normothermic blood car-
dioplegic perfusion. The retrograde blood flow that
passed through the myocardium and returned to the
aorta was much lower than the total retrograde perfu-
sion flow because of a large amount of shunting of
blood flow to the ventricular chambers. The release of
CK during retrograde continuous normothermic blood
cardioplegic perfusion may be overestimated because
total retrograde perfusion flow, rather than retrograde
flow through the myocardial tissue, was used to calcu-
late the release of CK.
Retrograde continuous normothermic blood cardio-
plegic perfusion has been enthusiastically endorsed by
several investigators, and its use has become wide-
spread. Blood distribution during retrograde flow of
normothermic blood cardioplegic perfusion to the
heart, however, is controversial. Gundry and cowork-
ers21 found that regional myocardial perfusion, includ-
ing the right side of the heart, is uniform during warm
continuous retrograde cardioplegic perfusion in human
beings. Other investigators have demonstrated that per-
fusion deficits exist during retrograde warm blood car-
dioplegic perfusion, especially in the right ventricle.10
Our previous study also demonstrated that retrograde
continuous normothermic blood cardioplegic perfusion
does not supply sufficient oxygen to maintain normal
energy metabolism in both ventricles, especially the
right ventricle, of normal hearts.12 In this study we
sought to assess the metabolic effects of antegrade and
retrograde continuous normothermic blood cardio-
plegic perfusion on the ischemic areas of each ventricle
in swine hearts with acute and complete occlusion of 2
major coronary arteries and to investigate whether ret-
rograde continuous normothermic blood cardioplegic
perfusion provides better protection to the ischemic
area than does antegrade continuous normothermic
blood cardioplegic perfusion. The absence of ischemic
metabolism would provide evidence for adequate oxy-
gen supply to the tissue. We have shown that neither
antegrade nor retrograde continuous normothermic
blood cardioplegic perfusion, as applied under our con-
ditions in a pig heart, maintains myocardial aerobic
metabolism in the ischemic areas of the right and left
ventricles, as indicated by significant declines in crea-
tine phosphate and ATP levels and in intracellular pH,
as well as by the increase in the inorganic phosphate
levels. Retrograde continuous normothermic blood car-
dioplegic perfusion did not provide better preservation
of normal energy metabolism in the ischemic area than
antegrade continuous normothermic blood cardioplegic
perfusion. Retrograde continuous normothermic blood
cardioplegic perfusion also appeared to result in more
severe ischemic metabolism in the right ventricle.
The findings indicate that retrograde continuous nor-
mothermic blood cardioplegic perfusion does not pro-
vide sufficient oxygen to the ischemic myocardium to
maintain normal metabolism at normal temperature.
These findings can be explained as follows: First, poor
capillary flow (nutritive flow) has been found in even
normal hearts as a result of shunting of flow away from
the capillary beds. A large amount of cardioplegic solu-
tion administered retrogradely travels through venous
collaterals, including the Thebesian veins, and drains
directly into the right ventricle.11,22 In studies with a
microsphere technique, it has been reported that the non-
nutritive flow of retrograde perfusion is between 64%
and 74%,10,23,24 which may underestimate true nonnutri-
tive flow as determined by capillary-dependent radioiso-
tope uptake.25 The limited nutritive flow supplied by ret-
rograde perfusion is inadequate to maintain aerobic
metabolism in arrested normothermic hearts.12 Second,
the model used in the study involves acute occlusion of
coronary arteries, and therefore only previously formed
collateral vessels exist in this model; these would be
fewer than those found in hearts with chronically occlud-
ed coronary arteries. It is believed that less nutritive flow
can reach the ischemic area in this acute ischemic model
than in chronically ischemic hearts. Third, although oxy-
gen consumption is reduced in arrested hearts, it remains
greater under the conditions of normothermia than those
of hypothermia. Therefore the limited amount of oxygen
provided by retrograde perfusion may be sufficient to
maintain normal metabolism during hypothermia (cold
cardioplegic perfusion) but is insufficient under condi-
tions of normothermia (normothermic cardioplegic per-
fusion). If only retrograde cardioplegic perfusion is used
in severely ischemic hearts, hypothermia may be neces-
sary to further reduce oxygen demands in accordance
with the limited oxygen supply. Under these circum-
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stances retrograde cold cardioplegic perfusion may pro-
vide better protection to the ischemic zone than retro-
grade warm cardioplegic perfusion. Because our experi-
ments were not designed to address differences between
cold and warm cardioplegic perfusion, however, we are
unable to provide any further conclusions on this issue,
particularly in this isolated model with acute complete
occlusion of coronary arteries. Fourth, to simulate a clin-
ical situation a retrograde catheter with an inflatable bal-
loon was used and placed in the coronary sinus for ret-
rograde delivery of cardioplegic solution. The inflatable
balloon may have blocked the middle and small cardiac
veins because these 2 veins open to the proximal part of
the coronary sinus, as in human hearts. Less retrograde
flow could therefore be delivered to the ventricles. This
problem may be resolved by placing purse-string sutures
around the orifice of the coronary sinus, rather than
using an inflatable balloon.26 However, the suturing
technique is not clinically practical. Finally, in this
model of complete occlusion of 2 major coronary arter-
ies, high resistance occurs in the arterial system of the
ischemic area. This may result in more shunting of ret-
rograde flow into nonischemic areas or into the ventric-
ular chambers. A recent study has shown that retrograde
cardioplegic perfusion does not improve the distribution
of cardioplegic solution in either the acutely ischemic
myocardial area or the zone of acute infarction in the
dog.27
One study has shown that retrograde warm blood car-
dioplegic perfusion preserves myocardial function in
the heart with an acute coronary arterial obstruction
better than does antegrade warm blood cardioplegic
perfusion.6 On the basis of the changes in energy
metabolites observed in our study, however, retrograde
warm blood cardioplegic perfusion does not appear to
preserve energy metabolism in the ischemic area better
than does antegrade warm blood cardioplegic perfu-
sion. It has also been reported that retrograde warm
blood cardioplegic perfusion results in greater anaero-
bic lactate production during and after cardioplegic
arrest than do other cardioplegic techniques.28,29
Our study also shows that during retrograde continu-
ous normothermic blood cardioplegic perfusion the
ischemic area of the right ventricle is less well protect-
ed than that of the left ventricle, as indicated by more
severe reductions in creatine phosphate and ATP levels
in the right ventricle during 60 minutes of occlusion of
the coronary arteries. This may be the result of less
nutritive flow to the right ventricle than to the left ven-
tricle as a result of large shunting10,11 and possible
blockage of the middle and small cardiac veins by the
retrograde catheter (inflated balloon) during retrograde
cardioplegic perfusion. In this study HPLC data also
showed that ATP was significantly reduced in even the
nonischemic area of the right ventricle during retro-
grade continuous normothermic blood cardioplegic per-
fusion, which is similar to our previous findings in nor-
mal pig hearts.12 The failure of the ATP level to recover
indicates that retrograde continuous normothermic
blood cardioplegic perfusion results in some damage to
both the normal area and the area of coronary occlusion.
The concentration of total creatine (creatine phosphate
plus creatine) was lower in the right ventricle than in the
left ventricle in both the antegrade and the retrograde
groups. This may not indicate any loss of creatine,
because the concentration of total creatine in the normal
area is also lower in the right ventricle than in the left
ventricle (81% of the left ventricle value; Table I).
This study is limited by the lack of functional assess-
ment of the heart after normokalemic reperfusion. Such
studies were not performed because of the considerable
technical difficulty of performing separate MR measure-
ments on 2 beating ventricles. In addition, this study was
performed in acutely ischemic isolated hearts. The
effects of both noncoronary collateral flow in the in vivo
situation and newly formed collateral circulations in the
diseased heart with chronically occluded coronary arter-
ies were absent. The data obtained with this model thus
cannot be completely translated into the clinical situa-
tion. However, animal models provide controlled exper-
imental conditions and allow measurements to be per-
formed that are often not feasible in human beings.
These results demonstrate that under our experimen-
tal conditions retrograde continuous normothermic
blood cardioplegic perfusion does not provide better
protection of high-energy metabolites and intracellular
pH in the ischemic area of hearts with acute and com-
plete occlusion of coronary arteries than does ante-
grade continuous normothermic blood cardioplegic
perfusion. During retrograde continuous normothermic
blood cardioplegic perfusion an ischemic area in the
right ventricle appears to be less protected than an
ischemic area in the left ventricle.
We thank Lori Shoemaker for biochemical analyses
(HPLC) and Monique St-Jean, Rachelle Perchaluk, and
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